New
Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →
Help us improve your experience. Please confirm your investor type:
ETF What's Up
Don’t Miss a Move in the ETF Market
Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.
03186 ETF · E Fund (HK) Solactive Biopharma Select Index ETF
The 03186 Exchange Traded Fund (ETF) is provided by E Fund Management. It is built to track an index: Solactive Biopharma Select Index. The 03186 ETF provides physical exposure, so by buying it you actually own parts of all the 86 underlying holdings. This share class generates a stream of income by distributing dividends.
Real-time data unavailable for 03186
LIVE
CLOSED
Last price
N/A
1M perf.
+14.41%
1M flows
+€3.3M
AuM
€3.7M
E/R
0.9%
Rating
Not rated
ESG Consensus®
03186
N/A
Performance & flows
March 31, 2026 → April 20, 2026
Create a free account to view the flows graph
03186
HK$16.74
+6.81%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | +12.40% | N/A | N/A | N/A | N/A | +6.81% | +6.81% | +14.41% | |
| Flows |
Key fund info
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
More details
NAV
4/20/2026
HK$16.74
1D NAV change
-0.75%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
86
Inception date
3/23/2026
Jurisdiction
Hong Kong
Distribution
Hong Kong
Legal structure
Open-end Fund
Base currency
HKD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
The investment objective is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive Biopharma Select Index (the “Index”).
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
New to Trackinsight?
For individual investors
Essentials
A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.
More fund data
Compare up to 3 funds
More screener filters
Choose your own screener columns from 100+ metrics
Lists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring
For professional investors
Enterprise
Trackinsight Enterprise addresses the everyday operational, regulatory, and analytical pain points faced by professional and institutional ETF investors, from selection to execution.
Request a free trialAdvertisement
Risk profile
Historical risk/return profile
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise
Exposure
Countries
Cayman Islands
30.99%
USA
25.56%
China
19.16%
Bermuda
6.09%
Hong Kong
4.41%
Switzerland
2.44%
Ireland
1.09%
Unavailable
9.30%
Other
0.96%
Sectors
Health Care
72.62%
Unavailable
27.38%
Diversification
Total weight of top 15 holdings out of 86
Top 15 holdings
Data as of March 31, 2026
AKESO INC
SHANGHAI JUNSHI BIOSCIENCES CO LTD
CNE1000062J1
INNOCARE PHARMA
REMEGEN
KEYMED BIOSCIENCES
SIMCERE PHARMACEUTICAL GROUP
3SBIO INC
Create a free account to view top holdings
ASCENTAGE PHARMA GROUP INTERNATIONAL
HUTCHISON CHINA MEDITECH
INNOVENT BIOLOGICS INC
CMS
EVEREST MEDICINES
SHANGHAI FOSUN PHARMACEUTICAL (GRP)I
KYG4790P1037
Create a free account to view top holdings
More risk metrics are available, exclusively in Trackinsight Enterprise
Sustainability
Integrates ESG criteria
No
SDG
More sustainability metrics are available, exclusively in Trackinsight Enterprise
Replication
Trackinsight replication rating:
Not rated
1-year trailing difference
As of March 31, 2026
Create a free account to view the replication graph
03186
N/A
Replication quality
Calculated over 12m, as of March 31, 2026
Tracking error
Tracking difference
1-year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Replication information
Index
Index ticker
Index dividend policy
Replication method
Replication model
Issuer
E Fund Management
E Fund Management ID Card
Number of funds
20
Total AuM
€18.69B
Expense ratio range
0.2% - 1.4%
Average expense ratio
0.6675%
Top 5 funds by E Fund Management
| AuM | ||
|---|---|---|
510310 | E Fund Seeded CSI 300 ETF | €17.93B |
512570 | E Fund CSI All Share Brokerage ETF | €323M |
512560 | E Fund CSI National Defense Index ETF | €107M |
512090 | E Fund MSCI China A Inclusion Index ETF | €79M |
03039 | E Fund (HK) HSI ESG Enhanced Index ETF | €70M |
Frequently asked questions about 03186
What does E Fund (HK) Solactive Biopharma Select Index ETF, 03186, invest in?
03186 is a Passive ETF. This ETF provides exposure to Equally Weighted Biotechnology Equities.
Which benchmark or index does 03186 replicate?
03186 tracks the Solactive Biopharma Select Index - HKD, through a full replication replication method.
What is the Total Expense ratio (TER) of 03186?
03186 carries a total expense ratio (TER) of 0.9%, indicating the annual cost for holding the fund.
When was 03186 launched?
03186 was introduced to the market on March 23, 2026. It trades on Hong Kong
Who is the ETF issuer of 03186?
E Fund (HK) Solactive Biopharma Select Index ETF, 03186, is provided by E Fund Management. Learn more about E Fund Management here.
What is the current assets under management (AUM) of 03186?
03186 oversees €3.7M in assets as of April 20, 2026.
How has 03186 performed lately?
Based on data from April 20, 2026, 03186 returned 12.40% over the past month.
What are the latest inflows or outflows for 03186?
As of April 20, 2026, 03186 recorded net flows of +€907K over the last month.
Does 03186 distribute dividends?
03186 follows a distributing dividend policy, meaning it pays out income to investors.
What are the main country or region exposures of 03186?
As of March 31, 2026, 03186 has significant geographic allocations in Cayman Islands, USA and China.
In which sector or theme does 03186 invest in?
As of March 31, 2026, 03186 focuses largely on Health Care.
How many securities does 03186 hold and how diversified is it?
As of March 31, 2026, 03186 holds 86 positions in its portfolio, with 34.95% of assets concentrated in its top 15 holdings.
What are the main positions in 03186?
As of March 31, 2026, 03186 top three holdings include AKESO INC, SHANGHAI JUNSHI BIOSCIENCES CO LTD and CNE1000062J1.
What is the base currency of 03186?
The base currency of 03186 is HKD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
